avacopan - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
TAVNEOS avacopan 10 mg hard capsule bottle
AUST R: 381053
Active ingredients:
avacopan

Dosage form:
Capsule, hard

Sponsor:
Seqirus Pty Ltd

Phone:
1800642865

Deletion from market:
31 Mar 2027

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Related information:

Management action:
Patients are advised to consult their healthcare professional to discuss alternative treatment options. A TGA web statement is available at: https://www.tga.gov.au/safety/recalls-and-other-market-actions/market-actions/withdrawal-tavneos-avacopan